JP2023123854A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023123854A5 JP2023123854A5 JP2023112365A JP2023112365A JP2023123854A5 JP 2023123854 A5 JP2023123854 A5 JP 2023123854A5 JP 2023112365 A JP2023112365 A JP 2023112365A JP 2023112365 A JP2023112365 A JP 2023112365A JP 2023123854 A5 JP2023123854 A5 JP 2023123854A5
- Authority
- JP
- Japan
- Prior art keywords
- chloro
- dihydroquinazolin
- oxo
- sulfonamide
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 24
- 125000001424 substituent group Chemical group 0.000 claims 20
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 19
- 229910052731 fluorine Inorganic materials 0.000 claims 19
- 150000003839 salts Chemical class 0.000 claims 19
- 125000002950 monocyclic group Chemical group 0.000 claims 18
- 229910052801 chlorine Inorganic materials 0.000 claims 15
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 15
- 125000005842 heteroatom Chemical group 0.000 claims 12
- 229910052757 nitrogen Inorganic materials 0.000 claims 12
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 11
- 229940124530 sulfonamide Drugs 0.000 claims 9
- 229910052739 hydrogen Inorganic materials 0.000 claims 8
- 125000000623 heterocyclic group Chemical group 0.000 claims 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 7
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 6
- 125000004122 cyclic group Chemical group 0.000 claims 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 6
- 229910052736 halogen Inorganic materials 0.000 claims 6
- 150000002367 halogens Chemical class 0.000 claims 6
- 125000002733 (C1-C6) fluoroalkyl group Chemical group 0.000 claims 5
- 125000002619 bicyclic group Chemical group 0.000 claims 5
- 229910052794 bromium Inorganic materials 0.000 claims 5
- 229910052760 oxygen Inorganic materials 0.000 claims 4
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 3
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims 3
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 125000004430 oxygen atom Chemical group O* 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- 229920006395 saturated elastomer Polymers 0.000 claims 3
- -1 3-fluoropyrrolidinyl Chemical group 0.000 claims 2
- QRUZRVZBEXOAFX-UHFFFAOYSA-N CCN(C)S(=O)(=O)NC1=C(C(=C(C=C1)F)NC2=C(C3=C(C=C2)N=CN(C3=O)C)C)Cl Chemical compound CCN(C)S(=O)(=O)NC1=C(C(=C(C=C1)F)NC2=C(C3=C(C=C2)N=CN(C3=O)C)C)Cl QRUZRVZBEXOAFX-UHFFFAOYSA-N 0.000 claims 2
- SHENFUUACGRLOZ-UHFFFAOYSA-N CN(C=NC(C1=C2Cl)=CC=C2NC(C(Cl)=C(C=C2)NS(N(C3)CC3F)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2Cl)=CC=C2NC(C(Cl)=C(C=C2)NS(N(C3)CC3F)(=O)=O)=C2F)C1=O SHENFUUACGRLOZ-UHFFFAOYSA-N 0.000 claims 2
- PVUNPHHPYSMTCY-UHFFFAOYSA-N ClC1=C(C=CC(=C1NC=1C(=C2C(N(C=NC2=CC=1)C)=O)C)F)NS(=O)(=O)N1CCCC1 Chemical compound ClC1=C(C=CC(=C1NC=1C(=C2C(N(C=NC2=CC=1)C)=O)C)F)NS(=O)(=O)N1CCCC1 PVUNPHHPYSMTCY-UHFFFAOYSA-N 0.000 claims 2
- MGXDSENFEMACMT-GFCCVEGCSA-N ClC1=C(C=CC(=C1NC=1C(=C2C(N(C=NC2=CC=1)C)=O)C)F)NS(=O)(=O)N1C[C@@H](CC1)F Chemical compound ClC1=C(C=CC(=C1NC=1C(=C2C(N(C=NC2=CC=1)C)=O)C)F)NS(=O)(=O)N1C[C@@H](CC1)F MGXDSENFEMACMT-GFCCVEGCSA-N 0.000 claims 2
- MJIOIJAVAFUYQI-UHFFFAOYSA-N CC(C(NC(C(Cl)=C(C=C1)NS(N(C2)CC2(COC)F)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(Cl)=C(C=C1)NS(N(C2)CC2(COC)F)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O MJIOIJAVAFUYQI-UHFFFAOYSA-N 0.000 claims 1
- PNEQCJRVAIVAIX-UHFFFAOYSA-N CC(C(NC(C(Cl)=C(C=C1)NS(N(C2)CC2(F)F)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(Cl)=C(C=C1)NS(N(C2)CC2(F)F)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O PNEQCJRVAIVAIX-UHFFFAOYSA-N 0.000 claims 1
- AFMCGJSSOZLSCM-UHFFFAOYSA-N CC(C(NC(C(Cl)=C(C=C1)NS(N(C2)CC2C#N)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(Cl)=C(C=C1)NS(N(C2)CC2C#N)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O AFMCGJSSOZLSCM-UHFFFAOYSA-N 0.000 claims 1
- SPCFADAMEYEQNZ-UHFFFAOYSA-N CC(C(NC(C(Cl)=C(C=C1)NS(N(C2)CC2F)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(Cl)=C(C=C1)NS(N(C2)CC2F)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O SPCFADAMEYEQNZ-UHFFFAOYSA-N 0.000 claims 1
- OFSAFCUAPLFXIB-UHFFFAOYSA-N CC(C(NC(C(Cl)=C(C=C1)NS(N(C2)CC2OC(F)(F)F)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(Cl)=C(C=C1)NS(N(C2)CC2OC(F)(F)F)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O OFSAFCUAPLFXIB-UHFFFAOYSA-N 0.000 claims 1
- MVGYFIHJKFZGMB-UHFFFAOYSA-N CC(C(NC(C(Cl)=C(C=C1)NS(N(C2)CC2OC(F)F)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(Cl)=C(C=C1)NS(N(C2)CC2OC(F)F)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O MVGYFIHJKFZGMB-UHFFFAOYSA-N 0.000 claims 1
- JUMRKSMOPIWHLX-UHFFFAOYSA-N CC(C(NC(C(Cl)=C(C=C1)NS(N(C2)CC2OC)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(Cl)=C(C=C1)NS(N(C2)CC2OC)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O JUMRKSMOPIWHLX-UHFFFAOYSA-N 0.000 claims 1
- AKTDIYHESLRZEC-UHFFFAOYSA-N CC(C(NC(C(Cl)=C(C=C1)NS(N(CC2)CC2(F)F)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(Cl)=C(C=C1)NS(N(CC2)CC2(F)F)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O AKTDIYHESLRZEC-UHFFFAOYSA-N 0.000 claims 1
- WCMPOFCVNWWSOT-UHFFFAOYSA-N CC(C(NC(C(Cl)=C(C=C1)NS(N(CC2)CC2C(F)(F)F)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(Cl)=C(C=C1)NS(N(CC2)CC2C(F)(F)F)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O WCMPOFCVNWWSOT-UHFFFAOYSA-N 0.000 claims 1
- CRHDZUTYEAZQSK-UHFFFAOYSA-N CC(C(NC(C(Cl)=C(C=C1)NS(N(CC2)CCC2O)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(Cl)=C(C=C1)NS(N(CC2)CCC2O)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O CRHDZUTYEAZQSK-UHFFFAOYSA-N 0.000 claims 1
- BVRQJLCECVSMAF-UHFFFAOYSA-N CC(C(NC(C(Cl)=C(C=C1)NS(N(CC2)CCC2OC)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(Cl)=C(C=C1)NS(N(CC2)CCC2OC)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O BVRQJLCECVSMAF-UHFFFAOYSA-N 0.000 claims 1
- YJMOMEPBIYHQPR-CYBMUJFWSA-N CC(C(NC(C(Cl)=C(C=C1)NS(N(CC2)C[C@@H]2OC)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(Cl)=C(C=C1)NS(N(CC2)C[C@@H]2OC)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O YJMOMEPBIYHQPR-CYBMUJFWSA-N 0.000 claims 1
- MGXDSENFEMACMT-LBPRGKRZSA-N CC(C(NC(C(Cl)=C(C=C1)NS(N(CC2)C[C@H]2F)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(Cl)=C(C=C1)NS(N(CC2)C[C@H]2F)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O MGXDSENFEMACMT-LBPRGKRZSA-N 0.000 claims 1
- JAGRPILYQQQQMI-UHFFFAOYSA-N CC(C(NC(C(Cl)=C(C=C1)NS(N(CC23)CC2C3F)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(Cl)=C(C=C1)NS(N(CC23)CC2C3F)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O JAGRPILYQQQQMI-UHFFFAOYSA-N 0.000 claims 1
- IYCZYUVMIHDGET-UHFFFAOYSA-N CC(C(NC(C(Cl)=C(C=C1)NS(N(CC2C3)CC23F)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(Cl)=C(C=C1)NS(N(CC2C3)CC23F)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O IYCZYUVMIHDGET-UHFFFAOYSA-N 0.000 claims 1
- RGKFBNUPNJYOSJ-BETUJISGSA-N CC(C(NC(C(Cl)=C(C=C1)NS(N(C[C@H]2F)C[C@@H]2F)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(Cl)=C(C=C1)NS(N(C[C@H]2F)C[C@@H]2F)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O RGKFBNUPNJYOSJ-BETUJISGSA-N 0.000 claims 1
- RGKFBNUPNJYOSJ-CHWSQXEVSA-N CC(C(NC(C(Cl)=C(C=C1)NS(N(C[C@H]2F)C[C@H]2F)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(Cl)=C(C=C1)NS(N(C[C@H]2F)C[C@H]2F)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O RGKFBNUPNJYOSJ-CHWSQXEVSA-N 0.000 claims 1
- LWTKFXDVZUDBBE-CXAGYDPISA-N CC(C(NC(C(Cl)=C(C=C1)NS(N(C[C@H]2OC)C[C@H]2F)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(Cl)=C(C=C1)NS(N(C[C@H]2OC)C[C@H]2F)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O LWTKFXDVZUDBBE-CXAGYDPISA-N 0.000 claims 1
- RHKKTDXPYLWYIW-UHFFFAOYSA-N CC(C(NC(C(Cl)=C(C=C1)NS(N2C(C3)C3CC2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(Cl)=C(C=C1)NS(N2C(C3)C3CC2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O RHKKTDXPYLWYIW-UHFFFAOYSA-N 0.000 claims 1
- FPOPYDGWBBNMCY-UHFFFAOYSA-N CC(C(NC(C(Cl)=C(C=C1)NS(N2C(C3)CC3C2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(Cl)=C(C=C1)NS(N2C(C3)CC3C2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O FPOPYDGWBBNMCY-UHFFFAOYSA-N 0.000 claims 1
- VLSUWJGUDZTDKJ-UHFFFAOYSA-N CC(C(NC(C(Cl)=C(C=C1)NS(N2C(CC3)CC3C2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(Cl)=C(C=C1)NS(N2C(CC3)CC3C2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O VLSUWJGUDZTDKJ-UHFFFAOYSA-N 0.000 claims 1
- SWYSCMMANIYGTK-UHFFFAOYSA-N CC(C(NC(C(Cl)=C(C=C1)NS(N2CC(C3)C3C2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(Cl)=C(C=C1)NS(N2CC(C3)C3C2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O SWYSCMMANIYGTK-UHFFFAOYSA-N 0.000 claims 1
- DLDHHMYZMWBUGI-UHFFFAOYSA-N CC(C(NC(C(Cl)=C(C=C1)NS(N2CC(COC(F)(F)F)C2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(Cl)=C(C=C1)NS(N2CC(COC(F)(F)F)C2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O DLDHHMYZMWBUGI-UHFFFAOYSA-N 0.000 claims 1
- NKIGPMUGQMPUIF-UHFFFAOYSA-N CC(C(NC(C(Cl)=C(C=C1)NS(N2CC(COC(F)F)C2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(Cl)=C(C=C1)NS(N2CC(COC(F)F)C2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O NKIGPMUGQMPUIF-UHFFFAOYSA-N 0.000 claims 1
- GPAVANATWGIMJS-UHFFFAOYSA-N CC(C(NC(C(Cl)=C(C=C1)NS(N2CC(COC)C2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(Cl)=C(C=C1)NS(N2CC(COC)C2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O GPAVANATWGIMJS-UHFFFAOYSA-N 0.000 claims 1
- VWKUMEMIYPXUGB-UHFFFAOYSA-N CC(C(NC(C(Cl)=C(C=C1)NS(N2CC(COCF)C2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(Cl)=C(C=C1)NS(N2CC(COCF)C2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O VWKUMEMIYPXUGB-UHFFFAOYSA-N 0.000 claims 1
- FJHYXSZHSDVMJD-UHFFFAOYSA-N CC(C(NC(C(Cl)=C(C=C1)NS(N2CC3(CC3)C2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(Cl)=C(C=C1)NS(N2CC3(CC3)C2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O FJHYXSZHSDVMJD-UHFFFAOYSA-N 0.000 claims 1
- KSBBCGZKZUNBGV-UHFFFAOYSA-N CC(C(NC(C(Cl)=C(C=C1)NS(N2CC3(CC3)CC2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(Cl)=C(C=C1)NS(N2CC3(CC3)CC2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O KSBBCGZKZUNBGV-UHFFFAOYSA-N 0.000 claims 1
- BFWVMTHJDRRORK-UHFFFAOYSA-N CC(C(NC(C(Cl)=C(C=C1)NS(N2CC3(CCC3)C2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(Cl)=C(C=C1)NS(N2CC3(CCC3)C2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O BFWVMTHJDRRORK-UHFFFAOYSA-N 0.000 claims 1
- AVIHZYPIRSUNFZ-UHFFFAOYSA-N CC(C(NC(C(Cl)=C(C=C1)NS(N2CCC2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(Cl)=C(C=C1)NS(N2CCC2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O AVIHZYPIRSUNFZ-UHFFFAOYSA-N 0.000 claims 1
- CWFGETWJYHWOFV-UHFFFAOYSA-N CC(C(NC(C(Cl)=C(C=C1)NS(N2CCCCC2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(Cl)=C(C=C1)NS(N2CCCCC2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O CWFGETWJYHWOFV-UHFFFAOYSA-N 0.000 claims 1
- KOGAGEINTVZOLT-UHFFFAOYSA-N CC(C(NC(C(Cl)=C(C=C1)NS(N2CCOCC2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(Cl)=C(C=C1)NS(N2CCOCC2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O KOGAGEINTVZOLT-UHFFFAOYSA-N 0.000 claims 1
- HZSDBRMQAPWREG-LLVKDONJSA-N CC(C(NC(C(Cl)=C(C=C1F)NS(N(CC2)C[C@@H]2F)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(Cl)=C(C=C1F)NS(N(CC2)C[C@@H]2F)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O HZSDBRMQAPWREG-LLVKDONJSA-N 0.000 claims 1
- AQKAQGIADLUFBL-GFCCVEGCSA-N CC(C(NC(C(Cl)=C(C=C1F)NS(N(CC2)C[C@@H]2OC)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(Cl)=C(C=C1F)NS(N(CC2)C[C@@H]2OC)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O AQKAQGIADLUFBL-GFCCVEGCSA-N 0.000 claims 1
- ZLPWKDYFFQCVKP-UHFFFAOYSA-N CC(C(NC(C(Cl)=C(C=C1F)NS(N2C(C3)CC3C2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(Cl)=C(C=C1F)NS(N2C(C3)CC3C2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O ZLPWKDYFFQCVKP-UHFFFAOYSA-N 0.000 claims 1
- LBELSVXBLDIGID-UHFFFAOYSA-N CC(C(NC(C(Cl)=C(C=C1F)NS(N2CC(C3)C3C2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(Cl)=C(C=C1F)NS(N2CC(C3)C3C2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O LBELSVXBLDIGID-UHFFFAOYSA-N 0.000 claims 1
- DURRQFANXYYQGX-UHFFFAOYSA-N CC(C(NC(C(Cl)=C(C=C1F)NS(N2CCCC2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(Cl)=C(C=C1F)NS(N2CCCC2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O DURRQFANXYYQGX-UHFFFAOYSA-N 0.000 claims 1
- DFOHHYOYRDWXAH-GFCCVEGCSA-N CC(C(NC(C(F)=C(C=C1)NS(N(CC2)C[C@@H]2F)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(F)=C(C=C1)NS(N(CC2)C[C@@H]2F)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O DFOHHYOYRDWXAH-GFCCVEGCSA-N 0.000 claims 1
- WDRDOTMGVBXKAK-UHFFFAOYSA-N CC(C(NC(C(F)=C(C=C1)NS(N2CCCC2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC(C(F)=C(C=C1)NS(N2CCCC2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O WDRDOTMGVBXKAK-UHFFFAOYSA-N 0.000 claims 1
- VQOJVGOHWDSPPE-CYBMUJFWSA-N CC(C(NC1=CC(Cl)=CC(NS(N(CC2)C[C@@H]2F)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC1=CC(Cl)=CC(NS(N(CC2)C[C@@H]2F)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O VQOJVGOHWDSPPE-CYBMUJFWSA-N 0.000 claims 1
- AXAZIGGUVNJFPW-CQSZACIVSA-N CC(C(NC1=CC(Cl)=CC(NS(N(CC2)C[C@@H]2OC)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC1=CC(Cl)=CC(NS(N(CC2)C[C@@H]2OC)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O AXAZIGGUVNJFPW-CQSZACIVSA-N 0.000 claims 1
- PDNYTDSKOXBEEP-UHFFFAOYSA-N CC(C(NC1=CC(Cl)=CC(NS(N2CCCC2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC1=CC(Cl)=CC(NS(N2CCCC2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O PDNYTDSKOXBEEP-UHFFFAOYSA-N 0.000 claims 1
- KAHHKTWRDPXLJW-GFCCVEGCSA-N CC(C(NC1=CC(F)=CC(NS(N(CC2)C[C@@H]2F)(=O)=O)=C1Cl)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC1=CC(F)=CC(NS(N(CC2)C[C@@H]2F)(=O)=O)=C1Cl)=CC=C1N=CN2C)=C1C2=O KAHHKTWRDPXLJW-GFCCVEGCSA-N 0.000 claims 1
- ZPKLBSRWTZCSTA-CQSZACIVSA-N CC(C(NC1=CC(F)=CC(NS(N(CC2)C[C@@H]2OC)(=O)=O)=C1Cl)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC1=CC(F)=CC(NS(N(CC2)C[C@@H]2OC)(=O)=O)=C1Cl)=CC=C1N=CN2C)=C1C2=O ZPKLBSRWTZCSTA-CQSZACIVSA-N 0.000 claims 1
- PGTSUVCQRKAFDR-UHFFFAOYSA-N CC(C(NC1=CC(F)=CC(NS(N2CCCC2)(=O)=O)=C1Cl)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC1=CC(F)=CC(NS(N2CCCC2)(=O)=O)=C1Cl)=CC=C1N=CN2C)=C1C2=O PGTSUVCQRKAFDR-UHFFFAOYSA-N 0.000 claims 1
- PSMGBLATSALNAZ-UHFFFAOYSA-N CC(C(NC1=CC(F)=CC(NS(N2CCCC2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(NC1=CC(F)=CC(NS(N2CCCC2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O PSMGBLATSALNAZ-UHFFFAOYSA-N 0.000 claims 1
- IPCBMZBWOGRGSU-UHFFFAOYSA-N CC(C(OC(C(Cl)=C(C=C1)NS(N(C2)CC2F)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(OC(C(Cl)=C(C=C1)NS(N(C2)CC2F)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O IPCBMZBWOGRGSU-UHFFFAOYSA-N 0.000 claims 1
- IXYZTIYJYUHCGK-UHFFFAOYSA-N CC(C(OC(C(Cl)=C(C=C1)NS(N(C2)CC2OC)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(OC(C(Cl)=C(C=C1)NS(N(C2)CC2OC)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O IXYZTIYJYUHCGK-UHFFFAOYSA-N 0.000 claims 1
- UQWVHMIQNAGWBQ-GFCCVEGCSA-N CC(C(OC(C(Cl)=C(C=C1)NS(N(CC2)C[C@@H]2F)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(OC(C(Cl)=C(C=C1)NS(N(CC2)C[C@@H]2F)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O UQWVHMIQNAGWBQ-GFCCVEGCSA-N 0.000 claims 1
- GQCJKDGCSVRYKQ-GFCCVEGCSA-N CC(C(OC(C(Cl)=C(C=C1)NS(N(CC2)C[C@@H]2OC(F)F)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(OC(C(Cl)=C(C=C1)NS(N(CC2)C[C@@H]2OC(F)F)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O GQCJKDGCSVRYKQ-GFCCVEGCSA-N 0.000 claims 1
- LMTCEQYJEFXHRD-CYBMUJFWSA-N CC(C(OC(C(Cl)=C(C=C1)NS(N(CC2)C[C@@H]2OC)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(OC(C(Cl)=C(C=C1)NS(N(CC2)C[C@@H]2OC)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O LMTCEQYJEFXHRD-CYBMUJFWSA-N 0.000 claims 1
- HUAKXDROVCBWFD-UHFFFAOYSA-N CC(C(OC(C(Cl)=C(C=C1)NS(N2CC(COC)C2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(OC(C(Cl)=C(C=C1)NS(N2CC(COC)C2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O HUAKXDROVCBWFD-UHFFFAOYSA-N 0.000 claims 1
- XWFWMRSRHNRUNT-UHFFFAOYSA-N CC(C(OC(C(Cl)=C(C=C1)NS(N2CCCC2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CC(C(OC(C(Cl)=C(C=C1)NS(N2CCCC2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O XWFWMRSRHNRUNT-UHFFFAOYSA-N 0.000 claims 1
- FGQROFVPYWNYET-UHFFFAOYSA-N CC(C1)(CN1S(NC(C=CC(F)=C1NC(C(C)=C23)=CC=C2N=CN(C)C3=O)=C1Cl)(=O)=O)F Chemical compound CC(C1)(CN1S(NC(C=CC(F)=C1NC(C(C)=C23)=CC=C2N=CN(C)C3=O)=C1Cl)(=O)=O)F FGQROFVPYWNYET-UHFFFAOYSA-N 0.000 claims 1
- RBVSIKCKZWYRAK-UHFFFAOYSA-N CC(C1)CN1S(NC(C=CC(F)=C1NC(C(C)=C23)=CC=C2N=CN(C)C3=O)=C1Cl)(=O)=O Chemical compound CC(C1)CN1S(NC(C=CC(F)=C1NC(C(C)=C23)=CC=C2N=CN(C)C3=O)=C1Cl)(=O)=O RBVSIKCKZWYRAK-UHFFFAOYSA-N 0.000 claims 1
- KFIFANCCPLESCM-UHFFFAOYSA-N CC(COC)(C1)CN1S(NC(C=CC(F)=C1NC(C(C)=C23)=CC=C2N=CN(C)C3=O)=C1Cl)(=O)=O Chemical compound CC(COC)(C1)CN1S(NC(C=CC(F)=C1NC(C(C)=C23)=CC=C2N=CN(C)C3=O)=C1Cl)(=O)=O KFIFANCCPLESCM-UHFFFAOYSA-N 0.000 claims 1
- URSQZUGJZJCLAO-UHFFFAOYSA-N CCC(C(NC(C(Cl)=C(C=C1)NS(N2CCCC2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O Chemical compound CCC(C(NC(C(Cl)=C(C=C1)NS(N2CCCC2)(=O)=O)=C1F)=CC=C1N=CN2C)=C1C2=O URSQZUGJZJCLAO-UHFFFAOYSA-N 0.000 claims 1
- RDQMAUXXRDJMGU-UHFFFAOYSA-N CCC(CC1)CN1S(NC(C=CC(F)=C1NC(C(Cl)=C23)=CC=C2N=CN(C)C3=O)=C1Cl)(=O)=O Chemical compound CCC(CC1)CN1S(NC(C=CC(F)=C1NC(C(Cl)=C23)=CC=C2N=CN(C)C3=O)=C1Cl)(=O)=O RDQMAUXXRDJMGU-UHFFFAOYSA-N 0.000 claims 1
- QPECHZKUKOKGEI-UHFFFAOYSA-N CCN(C)S(NC(C(Cl)=C1OC(C(C)=C23)=CC=C2N=CN(C)C3=O)=CC=C1F)(=O)=O Chemical compound CCN(C)S(NC(C(Cl)=C1OC(C(C)=C23)=CC=C2N=CN(C)C3=O)=CC=C1F)(=O)=O QPECHZKUKOKGEI-UHFFFAOYSA-N 0.000 claims 1
- OWNXSPNGQPJJFL-UHFFFAOYSA-N CCOC(C1)CN1S(NC(C=CC(F)=C1NC(C(C)=C23)=CC=C2N=CN(C)C3=O)=C1Cl)(=O)=O Chemical compound CCOC(C1)CN1S(NC(C=CC(F)=C1NC(C(C)=C23)=CC=C2N=CN(C)C3=O)=C1Cl)(=O)=O OWNXSPNGQPJJFL-UHFFFAOYSA-N 0.000 claims 1
- VROKNXOYZCZMKA-UHFFFAOYSA-N CCOC(C1)CN1S(NC(C=CC(F)=C1NC(C(Cl)=C23)=CC=C2N=CN(C)C3=O)=C1Cl)(=O)=O Chemical compound CCOC(C1)CN1S(NC(C=CC(F)=C1NC(C(Cl)=C23)=CC=C2N=CN(C)C3=O)=C1Cl)(=O)=O VROKNXOYZCZMKA-UHFFFAOYSA-N 0.000 claims 1
- BRYNXXLIZLVTMP-UHFFFAOYSA-N CCOC(C1)CN1S(NC(C=CC(F)=C1NC(C(F)=C23)=CC=C2N=CN(C)C3=O)=C1Cl)(=O)=O Chemical compound CCOC(C1)CN1S(NC(C=CC(F)=C1NC(C(F)=C23)=CC=C2N=CN(C)C3=O)=C1Cl)(=O)=O BRYNXXLIZLVTMP-UHFFFAOYSA-N 0.000 claims 1
- RDQMAUXXRDJMGU-GFCCVEGCSA-N CC[C@H](CC1)CN1S(NC(C=CC(F)=C1NC(C(Cl)=C23)=CC=C2N=CN(C)C3=O)=C1Cl)(=O)=O Chemical compound CC[C@H](CC1)CN1S(NC(C=CC(F)=C1NC(C(Cl)=C23)=CC=C2N=CN(C)C3=O)=C1Cl)(=O)=O RDQMAUXXRDJMGU-GFCCVEGCSA-N 0.000 claims 1
- OCACFKZEFVBMEZ-GFCCVEGCSA-N CC[C@H](CC1)CN1S(NC(C=CC(F)=C1NC(C(F)=C23)=CC=C2N=CN(C)C3=O)=C1Cl)(=O)=O Chemical compound CC[C@H](CC1)CN1S(NC(C=CC(F)=C1NC(C(F)=C23)=CC=C2N=CN(C)C3=O)=C1Cl)(=O)=O OCACFKZEFVBMEZ-GFCCVEGCSA-N 0.000 claims 1
- SSMRJKKTWMFTIP-SNVBAGLBSA-N CN(C=NC(C1=C2Br)=CC=C2NC(C(Cl)=C(C=C2)NS(N(CC3)C[C@@H]3F)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2Br)=CC=C2NC(C(Cl)=C(C=C2)NS(N(CC3)C[C@@H]3F)(=O)=O)=C2F)C1=O SSMRJKKTWMFTIP-SNVBAGLBSA-N 0.000 claims 1
- YFAWRFMROOYBCL-LLVKDONJSA-N CN(C=NC(C1=C2Br)=CC=C2NC(C(Cl)=C(C=C2)NS(N(CC3)C[C@@H]3OC)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2Br)=CC=C2NC(C(Cl)=C(C=C2)NS(N(CC3)C[C@@H]3OC)(=O)=O)=C2F)C1=O YFAWRFMROOYBCL-LLVKDONJSA-N 0.000 claims 1
- JZWUPGAGIMDVES-UHFFFAOYSA-N CN(C=NC(C1=C2Br)=CC=C2NC(C(Cl)=C(C=C2)NS(N3CCCC3)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2Br)=CC=C2NC(C(Cl)=C(C=C2)NS(N3CCCC3)(=O)=O)=C2F)C1=O JZWUPGAGIMDVES-UHFFFAOYSA-N 0.000 claims 1
- PIMFHTCJQOPFCA-UHFFFAOYSA-N CN(C=NC(C1=C2C#N)=CC=C2NC(C(Cl)=C(C=C2)NS(N3CCCC3)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2C#N)=CC=C2NC(C(Cl)=C(C=C2)NS(N3CCCC3)(=O)=O)=C2F)C1=O PIMFHTCJQOPFCA-UHFFFAOYSA-N 0.000 claims 1
- MPRLOVWPBANENO-UHFFFAOYSA-N CN(C=NC(C1=C2C=C)=CC=C2NC(C(Cl)=C(C=C2)NS(N3CCCC3)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2C=C)=CC=C2NC(C(Cl)=C(C=C2)NS(N3CCCC3)(=O)=O)=C2F)C1=O MPRLOVWPBANENO-UHFFFAOYSA-N 0.000 claims 1
- GCMDXZJHJGPFED-UHFFFAOYSA-N CN(C=NC(C1=C2Cl)=CC=C2NC(C(Cl)=C(C=C2)NS(N(C3)CC3(F)F)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2Cl)=CC=C2NC(C(Cl)=C(C=C2)NS(N(C3)CC3(F)F)(=O)=O)=C2F)C1=O GCMDXZJHJGPFED-UHFFFAOYSA-N 0.000 claims 1
- WYHDLVAKNYYIQZ-UHFFFAOYSA-N CN(C=NC(C1=C2Cl)=CC=C2NC(C(Cl)=C(C=C2)NS(N(C3)CC3OC(F)F)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2Cl)=CC=C2NC(C(Cl)=C(C=C2)NS(N(C3)CC3OC(F)F)(=O)=O)=C2F)C1=O WYHDLVAKNYYIQZ-UHFFFAOYSA-N 0.000 claims 1
- YIVMEZOFUWKXSZ-UHFFFAOYSA-N CN(C=NC(C1=C2Cl)=CC=C2NC(C(Cl)=C(C=C2)NS(N(C3)CC3OC)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2Cl)=CC=C2NC(C(Cl)=C(C=C2)NS(N(C3)CC3OC)(=O)=O)=C2F)C1=O YIVMEZOFUWKXSZ-UHFFFAOYSA-N 0.000 claims 1
- VOHBHOQRAVQOPO-UHFFFAOYSA-N CN(C=NC(C1=C2Cl)=CC=C2NC(C(Cl)=C(C=C2)NS(N(CC3)CC3(F)F)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2Cl)=CC=C2NC(C(Cl)=C(C=C2)NS(N(CC3)CC3(F)F)(=O)=O)=C2F)C1=O VOHBHOQRAVQOPO-UHFFFAOYSA-N 0.000 claims 1
- WDCARUAAIWOZNO-SNVBAGLBSA-N CN(C=NC(C1=C2Cl)=CC=C2NC(C(Cl)=C(C=C2)NS(N(CC3)C[C@@H]3F)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2Cl)=CC=C2NC(C(Cl)=C(C=C2)NS(N(CC3)C[C@@H]3F)(=O)=O)=C2F)C1=O WDCARUAAIWOZNO-SNVBAGLBSA-N 0.000 claims 1
- DTRGRTJBNTXUAV-SNVBAGLBSA-N CN(C=NC(C1=C2Cl)=CC=C2NC(C(Cl)=C(C=C2)NS(N(CC3)C[C@@H]3OC(F)F)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2Cl)=CC=C2NC(C(Cl)=C(C=C2)NS(N(CC3)C[C@@H]3OC(F)F)(=O)=O)=C2F)C1=O DTRGRTJBNTXUAV-SNVBAGLBSA-N 0.000 claims 1
- UGQRSDILVYYDFX-LLVKDONJSA-N CN(C=NC(C1=C2Cl)=CC=C2NC(C(Cl)=C(C=C2)NS(N(CC3)C[C@@H]3OC)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2Cl)=CC=C2NC(C(Cl)=C(C=C2)NS(N(CC3)C[C@@H]3OC)(=O)=O)=C2F)C1=O UGQRSDILVYYDFX-LLVKDONJSA-N 0.000 claims 1
- WDCARUAAIWOZNO-JTQLQIEISA-N CN(C=NC(C1=C2Cl)=CC=C2NC(C(Cl)=C(C=C2)NS(N(CC3)C[C@H]3F)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2Cl)=CC=C2NC(C(Cl)=C(C=C2)NS(N(CC3)C[C@H]3F)(=O)=O)=C2F)C1=O WDCARUAAIWOZNO-JTQLQIEISA-N 0.000 claims 1
- LWNVOPKVBMJXGE-UHFFFAOYSA-N CN(C=NC(C1=C2Cl)=CC=C2NC(C(Cl)=C(C=C2)NS(N3C(C4)CC4C3)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2Cl)=CC=C2NC(C(Cl)=C(C=C2)NS(N3C(C4)CC4C3)(=O)=O)=C2F)C1=O LWNVOPKVBMJXGE-UHFFFAOYSA-N 0.000 claims 1
- DQUZICYKXCUYJC-UHFFFAOYSA-N CN(C=NC(C1=C2Cl)=CC=C2NC(C(Cl)=C(C=C2)NS(N3CC(C4)C4C3)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2Cl)=CC=C2NC(C(Cl)=C(C=C2)NS(N3CC(C4)C4C3)(=O)=O)=C2F)C1=O DQUZICYKXCUYJC-UHFFFAOYSA-N 0.000 claims 1
- JCYQRYQCLZSGSG-UHFFFAOYSA-N CN(C=NC(C1=C2Cl)=CC=C2NC(C(Cl)=C(C=C2)NS(N3CC(COC(F)F)C3)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2Cl)=CC=C2NC(C(Cl)=C(C=C2)NS(N3CC(COC(F)F)C3)(=O)=O)=C2F)C1=O JCYQRYQCLZSGSG-UHFFFAOYSA-N 0.000 claims 1
- ZBPNOMACIADWMK-UHFFFAOYSA-N CN(C=NC(C1=C2Cl)=CC=C2NC(C(Cl)=C(C=C2)NS(N3CC(COC)C3)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2Cl)=CC=C2NC(C(Cl)=C(C=C2)NS(N3CC(COC)C3)(=O)=O)=C2F)C1=O ZBPNOMACIADWMK-UHFFFAOYSA-N 0.000 claims 1
- SEKLXUQUWUTSAN-UHFFFAOYSA-N CN(C=NC(C1=C2Cl)=CC=C2NC(C(Cl)=C(C=C2)NS(N3CC4(CCC4)C3)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2Cl)=CC=C2NC(C(Cl)=C(C=C2)NS(N3CC4(CCC4)C3)(=O)=O)=C2F)C1=O SEKLXUQUWUTSAN-UHFFFAOYSA-N 0.000 claims 1
- XXBYZUHAYJMUQZ-UHFFFAOYSA-N CN(C=NC(C1=C2Cl)=CC=C2NC(C(Cl)=C(C=C2)NS(N3CCCC3)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2Cl)=CC=C2NC(C(Cl)=C(C=C2)NS(N3CCCC3)(=O)=O)=C2F)C1=O XXBYZUHAYJMUQZ-UHFFFAOYSA-N 0.000 claims 1
- XGVMEUZFHRVBCR-SECBINFHSA-N CN(C=NC(C1=C2Cl)=CC=C2NC(C(Cl)=C(C=C2F)NS(N(CC3)C[C@@H]3F)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2Cl)=CC=C2NC(C(Cl)=C(C=C2F)NS(N(CC3)C[C@@H]3F)(=O)=O)=C2F)C1=O XGVMEUZFHRVBCR-SECBINFHSA-N 0.000 claims 1
- RRFOHTWODVGMCG-SNVBAGLBSA-N CN(C=NC(C1=C2Cl)=CC=C2NC(C(Cl)=C(C=C2F)NS(N(CC3)C[C@@H]3OC)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2Cl)=CC=C2NC(C(Cl)=C(C=C2F)NS(N(CC3)C[C@@H]3OC)(=O)=O)=C2F)C1=O RRFOHTWODVGMCG-SNVBAGLBSA-N 0.000 claims 1
- DGPYQSDVFZJCBJ-UHFFFAOYSA-N CN(C=NC(C1=C2Cl)=CC=C2NC(C(Cl)=C(C=C2F)NS(N3CCCC3)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2Cl)=CC=C2NC(C(Cl)=C(C=C2F)NS(N3CCCC3)(=O)=O)=C2F)C1=O DGPYQSDVFZJCBJ-UHFFFAOYSA-N 0.000 claims 1
- WYCLRAUHZYQGFP-SECBINFHSA-N CN(C=NC(C1=C2Cl)=CC=C2NC(C(F)=C(C=C2F)NS(N(CC3)C[C@@H]3F)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2Cl)=CC=C2NC(C(F)=C(C=C2F)NS(N(CC3)C[C@@H]3F)(=O)=O)=C2F)C1=O WYCLRAUHZYQGFP-SECBINFHSA-N 0.000 claims 1
- UUFJINIHPUDLSC-SNVBAGLBSA-N CN(C=NC(C1=C2Cl)=CC=C2NC(C(F)=C(C=C2F)NS(N(CC3)C[C@@H]3OC)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2Cl)=CC=C2NC(C(F)=C(C=C2F)NS(N(CC3)C[C@@H]3OC)(=O)=O)=C2F)C1=O UUFJINIHPUDLSC-SNVBAGLBSA-N 0.000 claims 1
- ZDRLEZHULJYDBL-UHFFFAOYSA-N CN(C=NC(C1=C2Cl)=CC=C2NC(C(F)=C(C=C2F)NS(N3CCCC3)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2Cl)=CC=C2NC(C(F)=C(C=C2F)NS(N3CCCC3)(=O)=O)=C2F)C1=O ZDRLEZHULJYDBL-UHFFFAOYSA-N 0.000 claims 1
- YDAOPAKIFICOQI-LLVKDONJSA-N CN(C=NC(C1=C2Cl)=CC=C2NC2=CC(Cl)=CC(NS(N(CC3)C[C@@H]3F)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2Cl)=CC=C2NC2=CC(Cl)=CC(NS(N(CC3)C[C@@H]3F)(=O)=O)=C2F)C1=O YDAOPAKIFICOQI-LLVKDONJSA-N 0.000 claims 1
- JRPLWUGQAGERQN-UHFFFAOYSA-N CN(C=NC(C1=C2Cl)=CC=C2OC(C(Cl)=C(C=C2)NS(N(C3)CC3F)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2Cl)=CC=C2OC(C(Cl)=C(C=C2)NS(N(C3)CC3F)(=O)=O)=C2F)C1=O JRPLWUGQAGERQN-UHFFFAOYSA-N 0.000 claims 1
- WXGVRHIGHHXVQA-UHFFFAOYSA-N CN(C=NC(C1=C2Cl)=CC=C2OC(C(Cl)=C(C=C2)NS(N(C3)CC3OC)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2Cl)=CC=C2OC(C(Cl)=C(C=C2)NS(N(C3)CC3OC)(=O)=O)=C2F)C1=O WXGVRHIGHHXVQA-UHFFFAOYSA-N 0.000 claims 1
- KATQNUPZOXFZFV-UHFFFAOYSA-N CN(C=NC(C1=C2Cl)=CC=C2OC(C(Cl)=C(C=C2)NS(N(CC3)CC3(F)F)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2Cl)=CC=C2OC(C(Cl)=C(C=C2)NS(N(CC3)CC3(F)F)(=O)=O)=C2F)C1=O KATQNUPZOXFZFV-UHFFFAOYSA-N 0.000 claims 1
- KGBJFGHGXFJEKD-SNVBAGLBSA-N CN(C=NC(C1=C2Cl)=CC=C2OC(C(Cl)=C(C=C2)NS(N(CC3)C[C@@H]3F)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2Cl)=CC=C2OC(C(Cl)=C(C=C2)NS(N(CC3)C[C@@H]3F)(=O)=O)=C2F)C1=O KGBJFGHGXFJEKD-SNVBAGLBSA-N 0.000 claims 1
- XLSVQMRXYWTWNF-SNVBAGLBSA-N CN(C=NC(C1=C2Cl)=CC=C2OC(C(Cl)=C(C=C2)NS(N(CC3)C[C@@H]3OC(F)F)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2Cl)=CC=C2OC(C(Cl)=C(C=C2)NS(N(CC3)C[C@@H]3OC(F)F)(=O)=O)=C2F)C1=O XLSVQMRXYWTWNF-SNVBAGLBSA-N 0.000 claims 1
- LZVAPBWZBQMCCG-LLVKDONJSA-N CN(C=NC(C1=C2Cl)=CC=C2OC(C(Cl)=C(C=C2)NS(N(CC3)C[C@@H]3OC)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2Cl)=CC=C2OC(C(Cl)=C(C=C2)NS(N(CC3)C[C@@H]3OC)(=O)=O)=C2F)C1=O LZVAPBWZBQMCCG-LLVKDONJSA-N 0.000 claims 1
- KGBJFGHGXFJEKD-JTQLQIEISA-N CN(C=NC(C1=C2Cl)=CC=C2OC(C(Cl)=C(C=C2)NS(N(CC3)C[C@H]3F)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2Cl)=CC=C2OC(C(Cl)=C(C=C2)NS(N(CC3)C[C@H]3F)(=O)=O)=C2F)C1=O KGBJFGHGXFJEKD-JTQLQIEISA-N 0.000 claims 1
- LQFWBQZSMJXYTE-UHFFFAOYSA-N CN(C=NC(C1=C2Cl)=CC=C2OC(C(Cl)=C(C=C2)NS(N3C(C4)CC4C3)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2Cl)=CC=C2OC(C(Cl)=C(C=C2)NS(N3C(C4)CC4C3)(=O)=O)=C2F)C1=O LQFWBQZSMJXYTE-UHFFFAOYSA-N 0.000 claims 1
- ZYVZLSDYVQTDTR-UHFFFAOYSA-N CN(C=NC(C1=C2Cl)=CC=C2OC(C(Cl)=C(C=C2)NS(N3CC(C4)C4C3)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2Cl)=CC=C2OC(C(Cl)=C(C=C2)NS(N3CC(C4)C4C3)(=O)=O)=C2F)C1=O ZYVZLSDYVQTDTR-UHFFFAOYSA-N 0.000 claims 1
- GTSKXAZTEOXAKK-UHFFFAOYSA-N CN(C=NC(C1=C2Cl)=CC=C2OC(C(Cl)=C(C=C2)NS(N3CC(COC)C3)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2Cl)=CC=C2OC(C(Cl)=C(C=C2)NS(N3CC(COC)C3)(=O)=O)=C2F)C1=O GTSKXAZTEOXAKK-UHFFFAOYSA-N 0.000 claims 1
- PXTMZDRNEPATNU-UHFFFAOYSA-N CN(C=NC(C1=C2Cl)=CC=C2OC(C(Cl)=C(C=C2)NS(N3CCCC3)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2Cl)=CC=C2OC(C(Cl)=C(C=C2)NS(N3CCCC3)(=O)=O)=C2F)C1=O PXTMZDRNEPATNU-UHFFFAOYSA-N 0.000 claims 1
- FHXQLGONEXOFCR-UHFFFAOYSA-N CN(C=NC(C1=C2F)=CC=C2NC(C(Cl)=C(C=C2)NS(N(C3)CC3(F)F)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2F)=CC=C2NC(C(Cl)=C(C=C2)NS(N(C3)CC3(F)F)(=O)=O)=C2F)C1=O FHXQLGONEXOFCR-UHFFFAOYSA-N 0.000 claims 1
- OSUBHKMYDYDZPQ-UHFFFAOYSA-N CN(C=NC(C1=C2F)=CC=C2NC(C(Cl)=C(C=C2)NS(N(C3)CC3F)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2F)=CC=C2NC(C(Cl)=C(C=C2)NS(N(C3)CC3F)(=O)=O)=C2F)C1=O OSUBHKMYDYDZPQ-UHFFFAOYSA-N 0.000 claims 1
- PKZRPBSWBBEDLS-UHFFFAOYSA-N CN(C=NC(C1=C2F)=CC=C2NC(C(Cl)=C(C=C2)NS(N(C3)CC3OC(F)F)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2F)=CC=C2NC(C(Cl)=C(C=C2)NS(N(C3)CC3OC(F)F)(=O)=O)=C2F)C1=O PKZRPBSWBBEDLS-UHFFFAOYSA-N 0.000 claims 1
- UGYOZGVWWBKDCO-UHFFFAOYSA-N CN(C=NC(C1=C2F)=CC=C2NC(C(Cl)=C(C=C2)NS(N(C3)CC3OC)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2F)=CC=C2NC(C(Cl)=C(C=C2)NS(N(C3)CC3OC)(=O)=O)=C2F)C1=O UGYOZGVWWBKDCO-UHFFFAOYSA-N 0.000 claims 1
- QFLUDEGVQLXYQS-UHFFFAOYSA-N CN(C=NC(C1=C2F)=CC=C2NC(C(Cl)=C(C=C2)NS(N(CC3)CC3(F)F)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2F)=CC=C2NC(C(Cl)=C(C=C2)NS(N(CC3)CC3(F)F)(=O)=O)=C2F)C1=O QFLUDEGVQLXYQS-UHFFFAOYSA-N 0.000 claims 1
- CTRMZSWBWUXVPF-SNVBAGLBSA-N CN(C=NC(C1=C2F)=CC=C2NC(C(Cl)=C(C=C2)NS(N(CC3)C[C@@H]3F)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2F)=CC=C2NC(C(Cl)=C(C=C2)NS(N(CC3)C[C@@H]3F)(=O)=O)=C2F)C1=O CTRMZSWBWUXVPF-SNVBAGLBSA-N 0.000 claims 1
- KURPWCGCQPRFHA-SNVBAGLBSA-N CN(C=NC(C1=C2F)=CC=C2NC(C(Cl)=C(C=C2)NS(N(CC3)C[C@@H]3OC(F)F)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2F)=CC=C2NC(C(Cl)=C(C=C2)NS(N(CC3)C[C@@H]3OC(F)F)(=O)=O)=C2F)C1=O KURPWCGCQPRFHA-SNVBAGLBSA-N 0.000 claims 1
- BNBAEMUVINMFTE-LLVKDONJSA-N CN(C=NC(C1=C2F)=CC=C2NC(C(Cl)=C(C=C2)NS(N(CC3)C[C@@H]3OC)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2F)=CC=C2NC(C(Cl)=C(C=C2)NS(N(CC3)C[C@@H]3OC)(=O)=O)=C2F)C1=O BNBAEMUVINMFTE-LLVKDONJSA-N 0.000 claims 1
- CTRMZSWBWUXVPF-JTQLQIEISA-N CN(C=NC(C1=C2F)=CC=C2NC(C(Cl)=C(C=C2)NS(N(CC3)C[C@H]3F)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2F)=CC=C2NC(C(Cl)=C(C=C2)NS(N(CC3)C[C@H]3F)(=O)=O)=C2F)C1=O CTRMZSWBWUXVPF-JTQLQIEISA-N 0.000 claims 1
- VRWJQPKRKKOLBH-UHFFFAOYSA-N CN(C=NC(C1=C2F)=CC=C2NC(C(Cl)=C(C=C2)NS(N3C(C4)CC4C3)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2F)=CC=C2NC(C(Cl)=C(C=C2)NS(N3C(C4)CC4C3)(=O)=O)=C2F)C1=O VRWJQPKRKKOLBH-UHFFFAOYSA-N 0.000 claims 1
- RPORXCOLSWKZIU-UHFFFAOYSA-N CN(C=NC(C1=C2F)=CC=C2NC(C(Cl)=C(C=C2)NS(N3CC(C4)C4C3)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2F)=CC=C2NC(C(Cl)=C(C=C2)NS(N3CC(C4)C4C3)(=O)=O)=C2F)C1=O RPORXCOLSWKZIU-UHFFFAOYSA-N 0.000 claims 1
- PYBMHCSLSDCEPK-UHFFFAOYSA-N CN(C=NC(C1=C2F)=CC=C2NC(C(Cl)=C(C=C2)NS(N3CC(COC(F)F)C3)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2F)=CC=C2NC(C(Cl)=C(C=C2)NS(N3CC(COC(F)F)C3)(=O)=O)=C2F)C1=O PYBMHCSLSDCEPK-UHFFFAOYSA-N 0.000 claims 1
- HJNGICBALISTBF-UHFFFAOYSA-N CN(C=NC(C1=C2F)=CC=C2NC(C(Cl)=C(C=C2)NS(N3CC(COC)C3)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2F)=CC=C2NC(C(Cl)=C(C=C2)NS(N3CC(COC)C3)(=O)=O)=C2F)C1=O HJNGICBALISTBF-UHFFFAOYSA-N 0.000 claims 1
- ACEYSKKZIBSLRS-UHFFFAOYSA-N CN(C=NC(C1=C2F)=CC=C2NC(C(Cl)=C(C=C2)NS(N3CC4(CCC4)C3)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2F)=CC=C2NC(C(Cl)=C(C=C2)NS(N3CC4(CCC4)C3)(=O)=O)=C2F)C1=O ACEYSKKZIBSLRS-UHFFFAOYSA-N 0.000 claims 1
- HPJJJNVHBBDKAM-UHFFFAOYSA-N CN(C=NC(C1=C2F)=CC=C2NC(C(Cl)=C(C=C2)NS(N3CCCC3)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2F)=CC=C2NC(C(Cl)=C(C=C2)NS(N3CCCC3)(=O)=O)=C2F)C1=O HPJJJNVHBBDKAM-UHFFFAOYSA-N 0.000 claims 1
- CXFQTCUFWXFHRX-SECBINFHSA-N CN(C=NC(C1=C2F)=CC=C2NC(C(Cl)=C(C=C2F)NS(N(CC3)C[C@@H]3F)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2F)=CC=C2NC(C(Cl)=C(C=C2F)NS(N(CC3)C[C@@H]3F)(=O)=O)=C2F)C1=O CXFQTCUFWXFHRX-SECBINFHSA-N 0.000 claims 1
- LWDHBGNPBRBMCB-SNVBAGLBSA-N CN(C=NC(C1=C2F)=CC=C2NC(C(Cl)=C(C=C2F)NS(N(CC3)C[C@@H]3OC)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2F)=CC=C2NC(C(Cl)=C(C=C2F)NS(N(CC3)C[C@@H]3OC)(=O)=O)=C2F)C1=O LWDHBGNPBRBMCB-SNVBAGLBSA-N 0.000 claims 1
- LSHAGHJHOYFAJG-UHFFFAOYSA-N CN(C=NC(C1=C2F)=CC=C2NC(C(Cl)=C(C=C2F)NS(N3C(C4)CC4C3)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2F)=CC=C2NC(C(Cl)=C(C=C2F)NS(N3C(C4)CC4C3)(=O)=O)=C2F)C1=O LSHAGHJHOYFAJG-UHFFFAOYSA-N 0.000 claims 1
- UQIBCWLIABMYOW-UHFFFAOYSA-N CN(C=NC(C1=C2F)=CC=C2NC(C(Cl)=C(C=C2F)NS(N3CCCC3)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2F)=CC=C2NC(C(Cl)=C(C=C2F)NS(N3CCCC3)(=O)=O)=C2F)C1=O UQIBCWLIABMYOW-UHFFFAOYSA-N 0.000 claims 1
- UBBNSWOHRFOOTN-LLVKDONJSA-N CN(C=NC(C1=C2F)=CC=C2NC2=CC(Cl)=CC(NS(N(CC3)C[C@@H]3F)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2F)=CC=C2NC2=CC(Cl)=CC(NS(N(CC3)C[C@@H]3F)(=O)=O)=C2F)C1=O UBBNSWOHRFOOTN-LLVKDONJSA-N 0.000 claims 1
- HTIZSUAQAFHLGJ-UHFFFAOYSA-N CN(C=NC(C1=C2F)=CC=C2OC(C(Cl)=C(C=C2)NS(N(C3)CC3F)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2F)=CC=C2OC(C(Cl)=C(C=C2)NS(N(C3)CC3F)(=O)=O)=C2F)C1=O HTIZSUAQAFHLGJ-UHFFFAOYSA-N 0.000 claims 1
- DZEGNYSNWCLIKP-UHFFFAOYSA-N CN(C=NC(C1=C2F)=CC=C2OC(C(Cl)=C(C=C2)NS(N(C3)CC3OC)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2F)=CC=C2OC(C(Cl)=C(C=C2)NS(N(C3)CC3OC)(=O)=O)=C2F)C1=O DZEGNYSNWCLIKP-UHFFFAOYSA-N 0.000 claims 1
- YGIQMGVXFZGNRJ-UHFFFAOYSA-N CN(C=NC(C1=C2F)=CC=C2OC(C(Cl)=C(C=C2)NS(N(CC3)CC3(F)F)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2F)=CC=C2OC(C(Cl)=C(C=C2)NS(N(CC3)CC3(F)F)(=O)=O)=C2F)C1=O YGIQMGVXFZGNRJ-UHFFFAOYSA-N 0.000 claims 1
- SJYBZAHXKHSOQT-SNVBAGLBSA-N CN(C=NC(C1=C2F)=CC=C2OC(C(Cl)=C(C=C2)NS(N(CC3)C[C@@H]3F)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2F)=CC=C2OC(C(Cl)=C(C=C2)NS(N(CC3)C[C@@H]3F)(=O)=O)=C2F)C1=O SJYBZAHXKHSOQT-SNVBAGLBSA-N 0.000 claims 1
- ANTUSYSPWARNOF-SNVBAGLBSA-N CN(C=NC(C1=C2F)=CC=C2OC(C(Cl)=C(C=C2)NS(N(CC3)C[C@@H]3OC(F)F)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2F)=CC=C2OC(C(Cl)=C(C=C2)NS(N(CC3)C[C@@H]3OC(F)F)(=O)=O)=C2F)C1=O ANTUSYSPWARNOF-SNVBAGLBSA-N 0.000 claims 1
- KJMBXZSNQJUUJY-LLVKDONJSA-N CN(C=NC(C1=C2F)=CC=C2OC(C(Cl)=C(C=C2)NS(N(CC3)C[C@@H]3OC)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2F)=CC=C2OC(C(Cl)=C(C=C2)NS(N(CC3)C[C@@H]3OC)(=O)=O)=C2F)C1=O KJMBXZSNQJUUJY-LLVKDONJSA-N 0.000 claims 1
- VMYBOKJQUPGAMX-UHFFFAOYSA-N CN(C=NC(C1=C2F)=CC=C2OC(C(Cl)=C(C=C2)NS(N3C(C4)CC4C3)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2F)=CC=C2OC(C(Cl)=C(C=C2)NS(N3C(C4)CC4C3)(=O)=O)=C2F)C1=O VMYBOKJQUPGAMX-UHFFFAOYSA-N 0.000 claims 1
- HWZZATCTUHRJGN-UHFFFAOYSA-N CN(C=NC(C1=C2F)=CC=C2OC(C(Cl)=C(C=C2)NS(N3CC(C4)C4C3)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2F)=CC=C2OC(C(Cl)=C(C=C2)NS(N3CC(C4)C4C3)(=O)=O)=C2F)C1=O HWZZATCTUHRJGN-UHFFFAOYSA-N 0.000 claims 1
- KXJPEQRQXTWQNV-UHFFFAOYSA-N CN(C=NC(C1=C2F)=CC=C2OC(C(Cl)=C(C=C2)NS(N3CC(COC)C3)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2F)=CC=C2OC(C(Cl)=C(C=C2)NS(N3CC(COC)C3)(=O)=O)=C2F)C1=O KXJPEQRQXTWQNV-UHFFFAOYSA-N 0.000 claims 1
- KMNZMQKQZOBISS-UHFFFAOYSA-N CN(C=NC(C1=C2F)=CC=C2OC(C(Cl)=C(C=C2)NS(N3CCCC3)(=O)=O)=C2F)C1=O Chemical compound CN(C=NC(C1=C2F)=CC=C2OC(C(Cl)=C(C=C2)NS(N3CCCC3)(=O)=O)=C2F)C1=O KMNZMQKQZOBISS-UHFFFAOYSA-N 0.000 claims 1
- 101000984753 Homo sapiens Serine/threonine-protein kinase B-raf Proteins 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- AGYNYNLUGPPKMA-UHFFFAOYSA-N O=C(C1=C2F)N(CF)C=NC1=CC=C2NC(C(Cl)=C(C=C1)NS(N2CCCC2)(=O)=O)=C1F Chemical compound O=C(C1=C2F)N(CF)C=NC1=CC=C2NC(C(Cl)=C(C=C1)NS(N2CCCC2)(=O)=O)=C1F AGYNYNLUGPPKMA-UHFFFAOYSA-N 0.000 claims 1
- 102100027103 Serine/threonine-protein kinase B-raf Human genes 0.000 claims 1
- YJMOMEPBIYHQPR-HPABDLATSA-N [2H]C([2H])([2H])O[C@H](CC1)CN1S(NC(C=CC(F)=C1NC(C(C)=C23)=CC=C2N=CN(C)C3=O)=C1Cl)(=O)=O Chemical compound [2H]C([2H])([2H])O[C@H](CC1)CN1S(NC(C=CC(F)=C1NC(C(C)=C23)=CC=C2N=CN(C)C3=O)=C1Cl)(=O)=O YJMOMEPBIYHQPR-HPABDLATSA-N 0.000 claims 1
- UGQRSDILVYYDFX-BINOJTDESA-N [2H]C([2H])([2H])O[C@H](CC1)CN1S(NC(C=CC(F)=C1NC(C(Cl)=C23)=CC=C2N=CN(C)C3=O)=C1Cl)(=O)=O Chemical compound [2H]C([2H])([2H])O[C@H](CC1)CN1S(NC(C=CC(F)=C1NC(C(Cl)=C23)=CC=C2N=CN(C)C3=O)=C1Cl)(=O)=O UGQRSDILVYYDFX-BINOJTDESA-N 0.000 claims 1
- BNBAEMUVINMFTE-BINOJTDESA-N [2H]C([2H])([2H])O[C@H](CC1)CN1S(NC(C=CC(F)=C1NC(C(F)=C23)=CC=C2N=CN(C)C3=O)=C1Cl)(=O)=O Chemical compound [2H]C([2H])([2H])O[C@H](CC1)CN1S(NC(C=CC(F)=C1NC(C(F)=C23)=CC=C2N=CN(C)C3=O)=C1Cl)(=O)=O BNBAEMUVINMFTE-BINOJTDESA-N 0.000 claims 1
- ACWZRVQXLIRSDF-UHFFFAOYSA-N binimetinib Chemical compound OCCONC(=O)C=1C=C2N(C)C=NC2=C(F)C=1NC1=CC=C(Br)C=C1F ACWZRVQXLIRSDF-UHFFFAOYSA-N 0.000 claims 1
- 229950003054 binimetinib Drugs 0.000 claims 1
- 229960005395 cetuximab Drugs 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 1
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063036522P | 2020-06-09 | 2020-06-09 | |
| US63/036,522 | 2020-06-09 | ||
| US202063116204P | 2020-11-20 | 2020-11-20 | |
| US63/116,204 | 2020-11-20 | ||
| US202163175655P | 2021-04-16 | 2021-04-16 | |
| US63/175,655 | 2021-04-16 | ||
| PCT/IB2021/054919 WO2021250521A1 (en) | 2020-06-09 | 2021-06-04 | 4-oxo-3,4-dihydroquinazolinon compounds for the treatment of braf-associated diseases and disorders |
| JP2022575381A JP7312335B2 (ja) | 2020-06-09 | 2021-06-04 | Ｂｒａｆ関連疾患および障害を処置するための４－オキソ－３，４－ジヒドロキナゾリノン化合物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022575381A Division JP7312335B2 (ja) | 2020-06-09 | 2021-06-04 | Ｂｒａｆ関連疾患および障害を処置するための４－オキソ－３，４－ジヒドロキナゾリノン化合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023123854A JP2023123854A (ja) | 2023-09-05 |
| JP2023123854A5 true JP2023123854A5 (https=) | 2024-05-29 |
Family
ID=76355554
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022575381A Active JP7312335B2 (ja) | 2020-06-09 | 2021-06-04 | Ｂｒａｆ関連疾患および障害を処置するための４－オキソ－３，４－ジヒドロキナゾリノン化合物 |
| JP2023112365A Pending JP2023123854A (ja) | 2020-06-09 | 2023-07-07 | Ｂｒａｆ関連疾患および障害を処置するための４－オキソ－３，４－ジヒドロキナゾリノン化合物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022575381A Active JP7312335B2 (ja) | 2020-06-09 | 2021-06-04 | Ｂｒａｆ関連疾患および障害を処置するための４－オキソ－３，４－ジヒドロキナゾリノン化合物 |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US12303509B2 (https=) |
| EP (1) | EP4161907A1 (https=) |
| JP (2) | JP7312335B2 (https=) |
| KR (1) | KR102904179B1 (https=) |
| CN (1) | CN116096710B (https=) |
| AU (1) | AU2021289163B2 (https=) |
| CL (1) | CL2022003326A1 (https=) |
| CO (1) | CO2022017876A2 (https=) |
| CR (1) | CR20220626A (https=) |
| DO (1) | DOP2022000282A (https=) |
| EC (1) | ECSP22093029A (https=) |
| IL (1) | IL298300B1 (https=) |
| MX (1) | MX2022015703A (https=) |
| PE (1) | PE20231651A1 (https=) |
| PY (1) | PY2146661A (https=) |
| TW (2) | TWI837478B (https=) |
| UA (1) | UA130198C2 (https=) |
| UY (1) | UY39261A (https=) |
| WO (1) | WO2021250521A1 (https=) |
| ZA (1) | ZA202212876B (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7667097B2 (ja) | 2019-06-14 | 2025-04-22 | ヤンセン ファーマシューティカ エヌ．ベー． | 置換ピラゾロ－ピリジンアミド及びｇｌｕｎ２ｂ受容体調節因子としてのその使用 |
| KR20220024403A (ko) | 2019-06-14 | 2022-03-03 | 얀센 파마슈티카 엔.브이. | 치환된 피라졸로-피라진 및 이들의 glun2b 수용체 조절제로서의 용도 |
| PL4073065T3 (pl) | 2019-12-10 | 2025-05-19 | F. Hoffmann-La Roche Ag | Nowe pochodne metylochinazolinonu |
| PH12022551118A1 (en) * | 2019-12-10 | 2023-09-18 | Hoffmann La Roche | New braf inhibitors as paradox breakers |
| WO2021250521A1 (en) * | 2020-06-09 | 2021-12-16 | Array Biopharma Inc. | 4-oxo-3,4-dihydroquinazolinon compounds for the treatment of braf-associated diseases and disorders |
| JP7834721B2 (ja) | 2020-08-28 | 2026-03-24 | アルビナス・オペレーションズ・インコーポレイテッド | 急速進行性線維肉腫タンパク質分解化合物及び関連する使用方法 |
| WO2022129259A1 (en) | 2020-12-18 | 2022-06-23 | F. Hoffmann-La Roche Ag | New quinazolinone derivatives |
| TWI825637B (zh) | 2021-03-31 | 2023-12-11 | 美商輝瑞股份有限公司 | 啶－１，６（２ｈ，７ｈ）－二酮 |
| WO2022261250A1 (en) | 2021-06-08 | 2022-12-15 | C4 Therapeutics, Inc. | Therapeutics for the degradation of mutant braf |
| EP4444710A1 (en) * | 2021-12-08 | 2024-10-16 | Array BioPharma Inc. | Crystalline form of n-(2-chloro-3-((5-chloro-3-methyl-4-oxo-3,4-dihydroquinazolin-6-yl)amino)-4-fluorophenyl)-3-fluoroazetidine-1-sulfonamide |
| CA3255688A1 (en) * | 2022-03-17 | 2023-09-21 | St. Jude Children's Research Hospital | TREATMENT OF A LOW-QUALITY GILOMA WITH MIRDAMETIN B |
| WO2023183470A1 (en) * | 2022-03-24 | 2023-09-28 | Vibliome Therapeutics, Llc | Modulators of protein kinases |
| WO2023230554A1 (en) | 2022-05-25 | 2023-11-30 | Pfizer Inc. | Combination of a braf inhibitor, an egfr inhibitor, and a pd-1 antagonist for the treatment of braf v600e-mutant, msi-h/dmmr colorectal cancer |
| CN117304205A (zh) * | 2022-06-20 | 2023-12-29 | 中国科学院广州生物医药与健康研究院 | 一种苯并咪唑类三元并环化合物、其药学上可接受的盐及其应用 |
| EP4584258A1 (en) | 2022-09-07 | 2025-07-16 | Arvinas Operations, Inc. | Rapidly accelerated fibrosarcoma (raf) degrading compounds and associated methods of use |
| CN120359214A (zh) * | 2022-12-15 | 2025-07-22 | 豪夫迈·罗氏有限公司 | 用于癌症治疗的组合疗法 |
| WO2024218632A1 (en) | 2023-04-17 | 2024-10-24 | Array Biopharma Inc. | Erk protein kinase inhibitors |
| WO2025014933A1 (en) * | 2023-07-10 | 2025-01-16 | Northwestern University | Targeting tim-3 in mapk-driven glioma |
| WO2025108405A1 (zh) * | 2023-11-22 | 2025-05-30 | 西藏海思科制药有限公司 | 作为激酶抑制剂的喹唑啉酮衍生物的制备及其用途 |
| WO2025176139A1 (zh) * | 2024-02-20 | 2025-08-28 | 海思科医药集团股份有限公司 | 一种喹唑啉酮衍生物的晶型及其制备方法和应用 |
| WO2026037755A1 (en) * | 2024-08-13 | 2026-02-19 | F. Hoffmann-La Roche Ag | New methylquinazolinone derivatives |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG2013013339A (en) | 2002-03-13 | 2014-12-30 | Array Biopharma Inc | N3 alkylated benzimidazole derivatives as mek inhibitors |
| US7144907B2 (en) | 2003-09-03 | 2006-12-05 | Array Biopharma Inc. | Heterocyclic inhibitors of MEK and methods of use thereof |
| US7517994B2 (en) | 2003-11-19 | 2009-04-14 | Array Biopharma Inc. | Heterocyclic inhibitors of MEK and methods of use thereof |
| CA2546353A1 (en) | 2003-11-19 | 2005-06-09 | Array Biopharma Inc. | Bicyclic inhibitors of mek and methods of use thereof |
| US7732616B2 (en) | 2003-11-19 | 2010-06-08 | Array Biopharma Inc. | Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof |
| BRPI0514691A (pt) | 2004-08-31 | 2008-06-17 | Astrazeneca Ab | composto ou um sal farmaceuticamente aceitável do mesmo, processo para preparar o mesmo, composição farmacêutica, e, uso de um composto ou um sal farmaceuticamente aceitável do mesmo |
| SG177981A1 (en) | 2005-05-18 | 2012-02-28 | Array Biopharma Inc | 4-(phenylamino)-6-oxo-1, 6-dihydropyridazine-3-carboxamide derivatives as mek inhibitors for the treatment of hyperproliferative diseases |
| WO2007113557A1 (en) | 2006-04-05 | 2007-10-11 | Astrazeneca Ab | Substituted quinazolines with anti-cancer activity |
| CN101415688A (zh) | 2006-04-05 | 2009-04-22 | 阿斯利康(瑞典)有限公司 | 具有b-raf抑制活性的喹唑啉酮衍生物 |
| CN101421253A (zh) | 2006-04-18 | 2009-04-29 | 阿斯利康(瑞典)有限公司 | 喹唑啉-4-酮衍生物、其制备方法及含有它们的药用组合物 |
| PE20081581A1 (es) | 2006-12-21 | 2008-11-12 | Plexxikon Inc | COMPUESTOS PIRROLO[2,3-b]PIRIDINAS COMO MODULADORES DE QUINASA |
| JP2010533729A (ja) | 2007-07-17 | 2010-10-28 | プレキシコン，インコーポレーテッド | キナーゼ調節のための化合物と方法、及びそのための適応 |
| SI2324008T1 (sl) | 2008-07-24 | 2012-08-31 | Nerviano Medical Sciences Srl | 3,4-diarilpirazoli kot protein-kinazni inhibitorji |
| JO3002B1 (ar) | 2009-08-28 | 2016-09-05 | Irm Llc | مركبات و تركيبات كمثبطات كيناز بروتين |
| WO2012118492A1 (en) * | 2011-03-01 | 2012-09-07 | Array Biopharma Inc. | Heterocyclic sulfonamides as raf inhibitors |
| CN108542906A (zh) | 2011-11-11 | 2018-09-18 | 诺华股份有限公司 | 治疗增生性疾病的方法 |
| CA3008312A1 (en) | 2016-01-06 | 2017-07-13 | Trillium Therapeutics Inc. | Novel fluorinated quinazoline derivatives as egfr inhibitors |
| JP7219218B2 (ja) | 2016-12-22 | 2023-02-07 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規のベンジルアミノ置換キナゾリンおよびｓｏｓ１阻害剤としての誘導体 |
| EP3684772B1 (en) | 2017-09-20 | 2023-12-06 | ABM Therapeutics Corporation | Cyclic iminopyrimidine derivatives as kinase inhibitors |
| WO2019071351A1 (en) | 2017-10-12 | 2019-04-18 | Trillium Therapeutics Inc. | NOVEL 4-ARYLOXYQUINAZOLINE FLUORIN DERIVATIVES AS EGFR INHIBITORS USEFUL FOR THE TREATMENT OF CANCERS |
| RU2678455C1 (ru) | 2018-06-01 | 2019-01-29 | Сергей Викторович Леонов | Кристаллическая форма n-(3-(5-(4-хлорофенил)-1н-пиразоло[3,4-в]пиридин-3-карбонил)-2,4-дифторофенил) пропан-1-сульфонамида, активный компонент, фармацевтическая композиция и лекарственное средство |
| WO2020055992A1 (en) | 2018-09-11 | 2020-03-19 | NetraDyne, Inc. | Inward/outward vehicle monitoring for remote reporting and in-cab warning enhancements |
| TWI817018B (zh) | 2019-06-28 | 2023-10-01 | 美商艾瑞生藥股份有限公司 | 用於治療ｂｒａｆ相關的疾病和失調症之化合物 |
| PH12022551118A1 (en) * | 2019-12-10 | 2023-09-18 | Hoffmann La Roche | New braf inhibitors as paradox breakers |
| PL4073065T3 (pl) | 2019-12-10 | 2025-05-19 | F. Hoffmann-La Roche Ag | Nowe pochodne metylochinazolinonu |
| WO2021250521A1 (en) * | 2020-06-09 | 2021-12-16 | Array Biopharma Inc. | 4-oxo-3,4-dihydroquinazolinon compounds for the treatment of braf-associated diseases and disorders |
-
2021
- 2021-06-04 WO PCT/IB2021/054919 patent/WO2021250521A1/en not_active Ceased
- 2021-06-04 JP JP2022575381A patent/JP7312335B2/ja active Active
- 2021-06-04 CR CR20220626A patent/CR20220626A/es unknown
- 2021-06-04 IL IL298300A patent/IL298300B1/en unknown
- 2021-06-04 TW TW110120375A patent/TWI837478B/zh active
- 2021-06-04 PE PE2022002894A patent/PE20231651A1/es unknown
- 2021-06-04 CN CN202180056068.XA patent/CN116096710B/zh active Active
- 2021-06-04 UA UAA202204519A patent/UA130198C2/uk unknown
- 2021-06-04 MX MX2022015703A patent/MX2022015703A/es unknown
- 2021-06-04 US US17/338,767 patent/US12303509B2/en active Active
- 2021-06-04 EP EP21731307.1A patent/EP4161907A1/en active Pending
- 2021-06-04 KR KR1020237000172A patent/KR102904179B1/ko active Active
- 2021-06-04 AU AU2021289163A patent/AU2021289163B2/en active Active
- 2021-06-04 TW TW112143784A patent/TW202426436A/zh unknown
- 2021-06-08 UY UY0001039261A patent/UY39261A/es unknown
- 2021-06-09 PY PY202102146661A patent/PY2146661A/es unknown
-
2022
- 2022-11-25 CL CL2022003326A patent/CL2022003326A1/es unknown
- 2022-11-25 ZA ZA2022/12876A patent/ZA202212876B/en unknown
- 2022-12-07 EC ECSENADI202293029A patent/ECSP22093029A/es unknown
- 2022-12-08 DO DO2022000282A patent/DOP2022000282A/es unknown
- 2022-12-09 CO CONC2022/0017876A patent/CO2022017876A2/es unknown
-
2023
- 2023-07-07 JP JP2023112365A patent/JP2023123854A/ja active Pending
-
2025
- 2025-04-16 US US19/180,762 patent/US20250241915A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023123854A5 (https=) | ||
| RU2440330C2 (ru) | ПРОИЗВОДНЫЕ 4-(2-АМИНО-1-ГИДРОКСИЭТИЛ)ФЕНОЛА, КАК АГОНИСТЫ β2 АДРЕНЕРГИЧЕСКОГО РЕЦЕПТОРА | |
| RU2373209C2 (ru) | Пирролотриазиновые соединения как ингибиторы киназ | |
| RU2010150786A (ru) | Пирролопиридины как ингибиторы киназы | |
| RU2486181C2 (ru) | Пиримидилциклопентаны как ингибиторы акт-протеинкиназ | |
| RU2455288C2 (ru) | Соединения и композиции 5-(4-(галогеналкокси)фенил)пиримидин-2-амина в качестве ингибиторов киназ | |
| JPWO2020061101A5 (https=) | ||
| JP2020033357A5 (https=) | ||
| RU2002121645A (ru) | Производные 2-аминоникотинамида и их применение в качестве ингибиторов vegf-рецептора тирозинкиназы | |
| RU2015122414A (ru) | Соединения n-пирролидинилмочевины, n'-пиразолилмочевины, тиомочевины, гуанидина и цианогуанидина как ингибиторы киназы trka | |
| JP2021523221A5 (https=) | ||
| JP2021529812A5 (https=) | ||
| RU2015106605A (ru) | Соединения замещенных пиразолонов и способы использования | |
| JP2018138577A5 (https=) | ||
| RU2011107437A (ru) | Ингибиторы кинуренин-3-моноксигеназы | |
| RU2008137526A (ru) | Ингибиторы киназы, основанные на гидантоине | |
| JP2017525757A5 (https=) | ||
| JP2013503903A5 (https=) | ||
| EA200400830A1 (ru) | ПИРИМИДИНОВЫЕ СОЕДИНЕНИЯ, ОТНОСЯЩИЕСЯ К A2b-СЕЛЕКТИВНЫМ АНТАГОНИСТАМ, ИХ СИНТЕЗ И ПРИМЕНЕНИЕ | |
| JP2013538801A5 (https=) | ||
| JP2016513660A5 (https=) | ||
| RU2005121667A (ru) | 5-замещенные пиразиновые или пиридиновые активаторы глюкокиназы | |
| RU2004104625A (ru) | Аналоги простагландинов в качестве агонистов рецептора ep4 | |
| RU2012116877A (ru) | Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы | |
| JP2013509431A5 (https=) |